Gonadotropin, Chorionic

Applications

NDAs, BLAs and generic ANDAs for this ingredient, oldest first; each opens its full history

Approved	Application	Sponsor	Supplements	Marketing
Mar 5, 1973	Chorionic GonadotropinBLA 17067 · New formulation or manufacturer	Fresenius Kabi USA	42	Marketed
Jan 15, 1974	Chorionic GonadotropinBLA 17016 · New formulation or manufacturer	Ferring	87	Marketed
Mar 26, 1974	Chorionic GonadotropinBLA 17054 · New formulation or manufacturer	Bel Mar	0	Discontinued
Dec 13, 1974	A.P.L.BLA 17055 · New formulation or manufacturer	Ferring	11	Discontinued
Oct 20, 1976	PregnylBLA 17692 · New formulation or manufacturer	Organon USA LLC	23	Marketed
—	Chorionic GonadotropinANDA 89312	Quad Pharms	0	Discontinued
—	Chorionic GonadotropinANDA 89313	Quad Pharms	0	Discontinued
—	Chorionic GonadotropinANDA 89314	Quad Pharms	0	Discontinued
—	Chorionic GonadotropinANDA 89315	Quad Pharms	0	Discontinued
—	Chorionic GonadotropinANDA 89316	Quad Pharms	0	Discontinued

Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA